Publication: The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome
dc.contributor.author | Bitzan, Martin | |
dc.date.accessioned | 2024-05-20T08:28:55Z | |
dc.date.available | 2024-05-20T08:28:55Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Abstract: The efficacy of the B cell-targeting drug rituximab (RTX) in childhood idiopathic nephrotic syndrome (INS) suggests that B cells may be implicated in disease pathogenesis. However, B cell characterization in children with INS remains limited. Here, using single-cell RNA sequencing, we demonstrate that a B cell transcriptional program poised for effector functions represents the major immune perturbation in blood samples from children with active INS. This transcriptional profile was associated with an extrafollicular B cell response marked by the expansion of atypical B cells (atBCs), marginal zonelike B cells, and antibody-secreting cells (ASCs). Flow cytometry of blood from 13 children with active INS and 24 healthy donors confirmed the presence of an extrafollicular B cell response denoted by the expansion of proliferating RTXsensitive extrafollicular (CXCR5– ) CD21low T-bet+ CD11c+ atBCs and short-lived T-bet+ ASCs in INS. Together, our study provides evidence for an extrafollicular origin for humoral immunity in active INS. | en_US |
dc.identifier.other | 204-2023.172 | |
dc.identifier.uri | https://repository.mbru.ac.ae/handle/1/1449 | |
dc.language.iso | en | en_US |
dc.subject | Idiopathic nephrotic syndrome (INS) | en_US |
dc.subject | Childhood | en_US |
dc.subject | Rituximab (RTX) | en_US |
dc.title | The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | en_US |